Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Perry, E. K. Articles by Wenk, G. L. Search for Related Content PubMed Citation Articles by Perry, E. K. Articles by Wenk, G. L. Other Neuroanatomy Neurotransmitters Autism

Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain

OBJECTIVE: Measures of cholinergic transmitter activity were investigated in patients with autism because of reported neuropathological abnormalities in cholinergic nuclei in the basal forebrain. METHOD: Levels of cholinergic enzyme and receptor activity were measured in the frontal and parietal cerebral cortex of deceased autistic adults, similarly aged normal adults without mental retardation, and nonautistic mentally retarded adults. The immunoreactivity levels of brain-derived neurotrophic factor and nerve growth factor were measured in the basal forebrain. RESULTS: There were no differences between the autistic and comparison groups in choline acetyltransferase or acetylcholinesterase activity in the cerebral cortex and basal forebrain or in muscarinic M₂ receptor or -bungarotoxin binding within the cortex. Cortical M₁ receptor binding was up to 30% lower than normal in the autistic subjects, and the difference reached significance in the parietal cortex. In both the parietal and frontal cortices, differences in nicotinic receptors assessed by [³H]epibatidine binding were significant and extensive (65%–73% lower in the autistic group than in the normal subjects); there were no differences in nicotine binding in the basal forebrain. Immunochemical analysis indicated lower levels of both the ₄ and ß₂ nicotinic receptor subunits in the parietal cortex. The M₁ receptor abnormality was not evident in the nonautistic group with mental retardation, although the lower [³H]epibatidine binding was apparent. In the basal forebrain, the level of brain-derived neurotrophic factor in the autistic group was three times as high as the level of the normal group. CONCLUSIONS: These neurochemical abnormalities implicate the cholinergic system in developmental disorders such as autism and suggest the potential for intervention based on cholinergic receptor modulation.

This article has been cited by other articles:

				S. M. Kassam, P. M. Herman, N. M. Goodfellow, N. C. Alves, and E. K. Lambe Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors J. Neurosci., August 27, 2008; 28(35): 8756 - 8764. [Abstract] [Full Text] [PDF]

				M. G. Chez Response to "Treating Autism Pharmacologically" J Child Neurol, August 1, 2007; 22(8): 1054 - 1055. [PDF]

				K. D. Mraz, J. Green, T. Dumont-Mathieu, S. Makin, and D. Fein Correlates of Head Circumference Growth in Infants Later Diagnosed With Autism Spectrum Disorders J Child Neurol, June 1, 2007; 22(6): 700 - 713. [Abstract] [PDF]

				M. G. Chez, Q. Burton, T. Dowling, M. Chang, P. Khanna, and C. Kramer Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability J Child Neurol, May 1, 2007; 22(5): 574 - 579. [Abstract] [PDF]

				R. L. Doyle, J. Frazier, T. J. Spencer, D. Geller, J. Biederman, and T. Wilens Donepezil in the Treatment of ADHD-Like Symptoms in Youths With Pervasive Developmental Disorder: A Case Series. J Atten Disord, February 1, 2006; 9(3): 543 - 549. [Abstract] [PDF]

				J. R. Turner and K. J. Kellar Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes J. Neurosci., October 5, 2005; 25(40): 9258 - 9265. [Abstract] [Full Text] [PDF]

				S. J. M. C. Palmen, H. van Engeland, P. R. Hof, and C. Schmitz Neuropathological findings in autism Brain, December 1, 2004; 127(12): 2572 - 2583. [Abstract] [Full Text] [PDF]

				R. Muhle, S. V. Trentacoste, and I. Rapin The Genetics of Autism Pediatrics, May 1, 2004; 113(5): e472 - e486. [Abstract] [Full Text] [PDF]

				R.-A. Muller, N. Kleinhans, N. Kemmotsu, K. Pierce, and E. Courchesne Abnormal Variability and Distribution of Functional Maps in Autism: An fMRI Study of Visuomotor Learning Am J Psychiatry, October 1, 2003; 160(10): 1847 - 1862. [Abstract] [Full Text] [PDF]

				S. Granon, P. Faure, and J.-P. Changeux Executive and social behaviors under nicotinic receptor regulation PNAS, August 5, 2003; 100(16): 9596 - 9601. [Abstract] [Full Text] [PDF]

				E. Courchesne, R. Carper, and N. Akshoomoff Evidence of Brain Overgrowth in the First Year of Life in Autism JAMA, July 16, 2003; 290(3): 337 - 344. [Abstract] [Full Text] [PDF]

				M. Lee, C. Martin-Ruiz, A. Graham, J. Court, E. Jaros, R. Perry, P. Iversen, M. Bauman, and E. Perry Nicotinic receptor abnormalities in the cerebellar cortex in autism Brain, July 1, 2002; 125(7): 1483 - 1495. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us